NCT/Study#

NCT02732275 /

DS3201-A-J101

A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects with Lymphomas

A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects with Lymphomas

DISEASE GROUP:
Lymphoma
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: